Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.
about
Picornavirus infection leading to immunosuppression.Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradientImmunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer.Rat models of type 1 diabetes: genetics, environment, and autoimmunity.IP-10 and type 1 diabetes: a question of time and location.Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recoveryTransforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.Helminth infection and type 1 diabetes.Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant.Virus-induced autoimmune diabetes in the LEW.1WR1 rat requires Iddm14 and a genetic locus proximal to the major histocompatibility complex.Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes.Immune evasion, immunopathology and the regulation of the immune system.Variability in the induction of experimental arthritis: Yersinia associated arthritis in Lewis rats.Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
P2860
Q34149230-91BF7A36-0D18-4A84-A709-71ED89A00B82Q34430207-FBB6C7AA-000D-4F1E-8583-6914E143B8F5Q34731064-09ECC1B5-626F-459E-9BCE-8BA5B6EDFAF8Q35603139-245D5847-977F-4387-AC63-1A92D4317B00Q35821238-73C303CD-03C5-4B18-B5A2-40F3EF9FA487Q35823978-5DF1B0C0-280C-4F24-AAB2-B88C6DBC89E1Q35934678-A170E5F0-AEF5-4FE5-B780-0B44EBDA6262Q36273819-57B28380-1DC6-45AF-8EA6-0AA0C70A256EQ36563528-EA73C48D-1782-4B49-8B44-13906DAD25D4Q37088203-1C0C2ACB-3BFB-4BC3-AB23-D812F2BA5D92Q37351448-1A8C8AAA-5BF9-48ED-A327-2F213A390799Q37429158-28EAF59B-D0C9-479B-ADB6-8495E5286988Q37569949-95EF7BEA-5A65-4599-B64C-72E52E3D17C9Q38273200-4FBECCC6-DC16-4099-8E22-709915011A1FQ41500734-0BCA1FB0-A08B-4562-8F21-D7685B054846Q48021507-081B024A-2DAC-4BEA-A152-541A37E4BEBE
P2860
Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Viruses as therapeutic agents. ...... ing general immune competence.
@ast
Viruses as therapeutic agents. ...... ing general immune competence.
@en
type
label
Viruses as therapeutic agents. ...... ing general immune competence.
@ast
Viruses as therapeutic agents. ...... ing general immune competence.
@en
prefLabel
Viruses as therapeutic agents. ...... ing general immune competence.
@ast
Viruses as therapeutic agents. ...... ing general immune competence.
@en
P2860
P356
P1476
Viruses as therapeutic agents. ...... ing general immune competence.
@en
P2093
M B Oldstone
P2860
P304
P356
10.1084/JEM.171.6.2077
P407
P577
1990-06-01T00:00:00Z